{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:36:26Z","timestamp":1787150186153,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00417-026-07149-9","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:38:28Z","timestamp":1775806708000},"page":"2537-2548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Janus Kinase inhibitors associated with reduced anterior uveitis risk in autoimmune diseases"],"prefix":"10.1007","volume":"264","author":[{"given":"Shiao-Ling","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ssu-Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hsiang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Fu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mey-Fann","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wen","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Xian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Jong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-0900","authenticated-orcid":false,"given":"Chien-Chih","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"7149_CR1","doi-asserted-by":"publisher","unstructured":"Egeberg A, Khalid U, Gislason GH, Mallbris L, Skov L, Hansen PR (2015) Association of Psoriatic Disease With Uveitis: A Danish Nationwide Cohort Study, (in eng), JAMA Dermatol 151(11):1200-5 https:\/\/doi.org\/10.1001\/jamadermatol.2015.1986","DOI":"10.1001\/jamadermatol.2015.1986"},{"issue":"3","key":"7149_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.semarthrit.2019.06.004","volume":"49","author":"JT Rosenbaum","year":"2019","unstructured":"Rosenbaum JT et al (Dec 2019) New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review, (in eng). Semin Arthritis Rheum 49(3):438\u2013445. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.06.004","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"7149_CR3","doi-asserted-by":"publisher","first-page":"103638","DOI":"10.1016\/j.autrev.2024.103638","volume":"23","author":"F Proft","year":"2024","unstructured":"Proft F, Duran TI, Ghoreschi K, Pleyer U, Siegmund B, Poddubnyy D (Oct 2024) Treatment strategies for Spondyloarthritis: Implementation of precision medicine - Or one size fits all concept? (in eng). Autoimmun Rev 23(10):103638. https:\/\/doi.org\/10.1016\/j.autrev.2024.103638","journal-title":"Autoimmun Rev"},{"issue":"1","key":"7149_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S et al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update, (in eng). Ann Rheum Dis 82(1):19\u201334. https:\/\/doi.org\/10.1136\/ard-2022-223296","journal-title":"Ann Rheum Dis"},{"key":"7149_CR5","doi-asserted-by":"publisher","unstructured":"Kharouf F, Gladman DD (2024) Advances in the management of psoriatic arthritis in adults, (in eng), Bmj, vol. 387, p. e081860, Nov 21 https:\/\/doi.org\/10.1136\/bmj-2024-081860","DOI":"10.1136\/bmj-2024-081860"},{"key":"7149_CR6","doi-asserted-by":"publisher","unstructured":"Su Y, Tao T, Liu X, Su W (Oct 2022) JAK-STAT signaling pathway in non-infectious uveitis, (in eng). Biochem Pharmacol 204:115236. https:\/\/doi.org\/10.1016\/j.bcp.2022.115236","DOI":"10.1016\/j.bcp.2022.115236"},{"key":"7149_CR7","doi-asserted-by":"publisher","unstructured":"Garweg JG, Straessle KA (2024) Janus Kinase Inhibitors as a Third-Line Therapy for Refractory Endogenous Noninfectious Uveitis, (in eng), Ocul Immunol Inflamm, pp. 1\u20138, May 6 https:\/\/doi.org\/10.1080\/09273948.2024.2348125","DOI":"10.1080\/09273948.2024.2348125"},{"key":"7149_CR8","doi-asserted-by":"publisher","unstructured":"Huang Z et al (2023) Therapeutic Effects of Upadacitinib on Experimental Autoimmune Uveitis: Insights From Single-Cell Analysis, (in eng), Invest Ophthalmol Vis Sci, vol. 64, no. 12, p. 28, Sep 1 https:\/\/doi.org\/10.1167\/iovs.64.12.28","DOI":"10.1167\/iovs.64.12.28"},{"key":"7149_CR9","doi-asserted-by":"publisher","first-page":"1439338","DOI":"10.3389\/fmed.2024.1439338","volume":"11","author":"A Vitale","year":"2024","unstructured":"Vitale A et al (2024) Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries. Front Med (Lausanne) 11:1439338. https:\/\/doi.org\/10.3389\/fmed.2024.1439338. (in eng)","journal-title":"Front Med (Lausanne)"},{"key":"7149_CR10","unstructured":"A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis - Including a Sub-study in Japanese Patients [Online] Available: https:\/\/clinicaltrials.gov\/study\/NCT01138657"},{"key":"7149_CR11","unstructured":"Phase A 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects With Active Noninfectious Uveitis [Online] Available: https:\/\/clinicaltrials.gov\/study\/NCT03207815"},{"key":"7149_CR12","unstructured":"Phase A 2, Randomized Double-Masked, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Active Non-Infectious Intermediate-, Posterior-, and Panuveitis [Online] Available: https:\/\/clinicaltrials.gov\/study\/NCT05523765"},{"key":"7149_CR13","doi-asserted-by":"publisher","unstructured":"Bechman K et al (2024) Incidence of Uveitis in Patients With Axial Spondylarthritis Treated With Biologics or Targeted Synthetics: A Systematic Review and Network Meta-Analysis, (in eng), Arthritis Rheumatol, vol. 76, no. 5, pp. 704\u2013714, May https:\/\/doi.org\/10.1002\/art.42788","DOI":"10.1002\/art.42788"},{"key":"7149_CR14","doi-asserted-by":"publisher","unstructured":"LaMattina KC, Goldstein DA (2017) Adalimumab for the treatment of uveitis, (in eng), Expert Rev Clin Immunol, vol. 13, no. 3, pp. 181\u2013188, Mar https:\/\/doi.org\/10.1080\/1744666x.2017.1288097","DOI":"10.1080\/1744666x.2017.1288097"},{"key":"7149_CR15","doi-asserted-by":"publisher","unstructured":"Joltikov KA, Lobo-Chan AM (2021) Epidemiology and Risk Factors in Non-infectious Uveitis: A Systematic Review, (in eng), Front Med (Lausanne), vol. 8, p. 695904. https:\/\/doi.org\/10.3389\/fmed.2021.695904","DOI":"10.3389\/fmed.2021.695904"},{"key":"7149_CR16","doi-asserted-by":"publisher","unstructured":"Pillar S, Amer R The association between vitamin D and uveitis: A comprehensive review, (in eng), Surv Ophthalmol, vol. 67, no. 2, pp. 321\u2013330, Mar-Apr 2022. https:\/\/doi.org\/10.1016\/j.survophthal.2021.07.006","DOI":"10.1016\/j.survophthal.2021.07.006"},{"issue":"6","key":"7149_CR17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nm1585","volume":"13","author":"A Amadi-Obi","year":"2007","unstructured":"Amadi-Obi A et al (Jun 2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1, (in eng). Nat Med 13(6):711\u2013718. https:\/\/doi.org\/10.1038\/nm1585","journal-title":"Nat Med"},{"key":"7149_CR18","doi-asserted-by":"publisher","unstructured":"Escobar T, Yu CR, Muljo SA, Egwuagu CE (2013) STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis, (in eng), Invest Ophthalmol Vis Sci, vol. 54, no. 6, pp. 4017-25, Jun 10 https:\/\/doi.org\/10.1167\/iovs.13-11937","DOI":"10.1167\/iovs.13-11937"},{"key":"7149_CR19","doi-asserted-by":"publisher","unstructured":"Liu X, Lee YS, Yu CR, Egwuagu CE (2008) 1 (May Loss of STAT3 in CD4\u2009+\u2009T cells prevents development of experimental autoimmune diseases, (in eng). J Immunol 180(9):6070\u20136076. https:\/\/doi.org\/10.4049\/jimmunol.180.9.6070","DOI":"10.4049\/jimmunol.180.9.6070"},{"key":"7149_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jaut.2015.05.011","volume":"62","author":"C He III","year":"2015","unstructured":"He C, Yu CR, Sun L, Mahdi RM, Larkin J 3rd, and, Egwuagu CE (Aug 2015) Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis, (in eng). J Autoimmun 62:31\u201338. https:\/\/doi.org\/10.1016\/j.jaut.2015.05.011","journal-title":"J Autoimmun"},{"key":"7149_CR21","doi-asserted-by":"publisher","unstructured":"Luger D et al Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category, (in eng). J Exp Med,205, 4, pp. 799\u2013810, Apr 14 2008. IF: 10.6 Q1B1 https:\/\/doi.org\/10.1084\/jem.20071258","DOI":"10.1084\/jem.20071258"},{"key":"7149_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ajoc.2018.12.001","volume":"13","author":"MA Paley","year":"2019","unstructured":"Bauermann P, Heiligenhaus A, Heinz C (2019) Effect of Janus Kinase Inhibitor Treatment on Anterior Uveitis and Associated Macular Edema in an Adult Patient with Juvenile Idiopathic Arthritis, (in eng), Ocul Immunol Inflamm, vol. 27, no. 8, pp. 1232\u20131234. IF: 2.0 Q2 B4 https:\/\/doi.org\/10.1080\/09273948.2019.1605453","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"2","key":"7149_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10067-022-06435-1","volume":"42","author":"Y Deng","year":"2023","unstructured":"Paley MA, Karacal H, Rao PK, Margolis TP, Miner JJ (Mar 2019) Tofacitinib for refractory uveitis and scleritis, (in eng). Am J Ophthalmol Case Rep 13:53\u201355. IF: NA NA NA https:\/\/doi.org\/10.1016\/j.ajoc.2018.12.001","journal-title":"Clin Rheumatol"},{"issue":"6","key":"7149_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11926-024-01144-x","volume":"26","author":"SP Raychaudhuri","year":"2024","unstructured":"Deng Y et al (2023) JAK-STAT signaling pathway-related gene single nucleotide polymorphisms and susceptibility to ankylosing spondylitis in eastern Chinese Han population, (in eng), Clin Rheumatol 42(2):549\u2013562 IF: 2.8 Q2 B3 https:\/\/doi.org\/10.1007\/s10067-022-06435-1","journal-title":"Curr Rheumatol Rep"},{"key":"7149_CR25","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1158\/1535-7163.Mct-22-0323","volume":"21","author":"RP Agashe","year":"2022","unstructured":"Raychaudhuri SP, Shah RJ, Banerjee S, Raychaudhuri SK (Jun 2024) Signaling and Beyond in the Pathogenesis of Spondyloarthritis and Their Clinical Significance, (in eng). Curr Rheumatol Rep 26(6):204\u2013213. IF: 3.9 Q1 B2 https:\/\/doi.org\/10.1007\/s11926-024-01144-x","journal-title":"Mol Cancer Ther"},{"key":"7149_CR26","doi-asserted-by":"publisher","first-page":"1271102","DOI":"10.3389\/fimmu.2023.1271102","volume":"14","author":"R Pandey","year":"2023","unstructured":"Agashe RP, Lippman SM, Kurzrock RJAK Not Just Another Kinase, (in eng). Mol Cancer Ther, 21, 12, pp. 1757\u20131764, Dec 2 2022. Mct-22-0323 IF: 5.5 Q1 B2 https:\/\/doi.org\/10.1158\/1535-7163. (in eng)","journal-title":"Front Immunol"},{"key":"7149_CR27","doi-asserted-by":"publisher","unstructured":"Pandey R, Bakay M, Hakonarson H (2023) SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis. Front Immunol 14:1271102. IF: 5.9 Q1 B2. (in eng) https:\/\/doi.org\/10.3389\/fimmu.2023.1271102","DOI":"10.3389\/fimmu.2023.1271102"},{"key":"7149_CR28","doi-asserted-by":"publisher","unstructured":"Juan HY, Sheu SJ, Hwang DK (2024) Review of Janus Kinase Inhibitors as Therapies for Noninfectious Uveitis, (in eng). J Ocul Pharmacol Ther Sep 24. IF: 2.1 Q2 B4 https:\/\/doi.org\/10.1089\/jop.2024.0100","DOI":"10.1089\/jop.2024.0100"},{"key":"7149_CR29","doi-asserted-by":"publisher","unstructured":"Lim LL, Fraunfelder FW, Rosenbaum JT (2007) Do tumor necrosis factor inhibitors cause uveitis? A registry-based study, (in eng), Arthritis Rheum, vol. 56, no. 10, pp.3248-52, Oct IF: NA NA NA https:\/\/doi.org\/10.1002\/art.22918","DOI":"10.1002\/art.22918"},{"key":"7149_CR30","doi-asserted-by":"publisher","unstructured":"Roche D, Badard M, Boyer L, Lafforgue P, Pham T (2021) 16 (Jul Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials. (in eng) Arthritis Res Ther 23(1):192. IF: 4.6 Q1 B2 https:\/\/doi.org\/10.1186\/s13075-021-02549-0","DOI":"10.1186\/s13075-021-02549-0"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07149-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07149-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07149-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:21:52Z","timestamp":1787149312000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07149-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["7149"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07149-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received ethical approval from the Institutional Review Board of Taichung Veterans General Hospital (IRB NO: CE24430C)","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Patients and the public were not directly involved in the design, recruitment, or conduct of this study, as it was based on retrospective analysis of de-identified electronic health records obtained from the TriNetX global research network.","order":2,"name":"Ethics","label":"Consent to participate \/ publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared there is no conflict of financial or non-financial interests.","order":3,"name":"Ethics","label":"Disclosure of potential conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}